Windlas Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H5O01029
  • NSEID: WINDLAS
  • BSEID: 543329
INR
731.55
4.75 (0.65%)
BSENSE

Mar 23

BSE+NSE Vol: 49.66 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003519,
    "name": "Windlas Biotech",
    "stock_name": "Windlas Biotech",
    "full_name": "Windlas Biotech Ltd",
    "name_url": "stocks-analysis/windlas-biotech",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "731.55",
    "chg": 4.75,
    "chgp": "0.65%",
    "dir": 1,
    "prev_price": "726.80",
    "mcapval": "1,555.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543329,
    "symbol": "WINDLAS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0H5O01029",
    "curr_date": "Mar 23",
    "curr_time": "",
    "bse_nse_vol": "49.66 k",
    "exc_status": "Active",
    "traded_date": "Mar 23, 2026",
    "traded_date_str": "2026 03 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/windlas-biotech-1003519-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Windlas Biotech Ltd Valuation Shifts to Fair Amid Sector Comparisons",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-valuation-shifts-to-fair-amid-sector-comparisons-3906260",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_valuationdot_3906260.png",
        "date": "2026-03-23 08:01:12",
        "description": "Windlas Biotech Ltd has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating, reflecting evolving market perceptions amid a challenging sector backdrop. Despite a modest day gain of 1.90%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest a more tempered price attractiveness compared to its historical averages and peer group benchmarks."
      },
      {
        "title": "Windlas Biotech’s Mixed Week: +0.01% Price, -0.28% Sensex Tell the Story",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotechs-mixed-week-001-price--028-sensex-tell-the-story-3905113",
        "imagepath": "",
        "date": "2026-03-21 12:01:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> Stock hits 52-week low at Rs.699.35 amid continued downtrend</p>\n                    <p><strong>17 Mar:</strong> Price rebounds sharply by 2.21% to Rs.724.15</p>\n                    <p><strong>18 Mar:</strong> Further gains of 1.12% to Rs.732.25</p>\n                    <p><strong>19 Mar:</strong> Sharp decline of 1.99% to Rs.717.65 on heavy market sell-off</p>\n                    <p><strong>20 Mar:</strong> Recovery with 1.27% gain to close at Rs.726.80</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.726.75</div></div>\n                  ..."
      },
      {
        "title": "Windlas Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/windlas-biotech-ltd-is-rated-sell-3905019",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_mojoScore_3905019.png",
        "date": "2026-03-21 10:10:03",
        "description": "Windlas Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Windlas Biotech Ltd Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-falls-to-52-week-low-amidst-continued-downtrend-3893795",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_priceRelatedfactors_3893795.png",
        "date": "2026-03-16 11:49:40",
        "description": "Windlas Biotech Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.699.35, marking a significant decline amid broader market pressures and company-specific performance factors."
      },
      {
        "title": "Windlas Biotech Valuation Shifts to Fair Amidst Sector Comparisons",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-valuation-shifts-to-fair-amidst-sector-comparisons-3892675",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_valuationdot_3892675.png",
        "date": "2026-03-16 08:01:24",
        "description": "Windlas Biotech Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating as of early February 2026. This change reflects evolving market perceptions amid a competitive pharmaceutical and biotechnology sector, with key valuation multiples such as price-to-earnings (P/E) and price-to-book value (P/BV) adjusting relative to historical averages and peer benchmarks."
      },
      {
        "title": "Windlas Biotech Declines 2.24% Amid Valuation Shift and Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-declines-224-amid-valuation-shift-and-bearish-momentum-3890591",
        "imagepath": "",
        "date": "2026-03-14 10:06:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>09 Mar:</strong> Stock hits 52-week low at Rs.708.90 amid market downturn</p>\n                    <p><strong>09 Mar:</strong> Technical downgrade to Sell rating confirmed bearish momentum</p>\n                    <p><strong>09 Mar:</strong> Valuation shifts to attractive rating despite price weakness</p>\n                    <p><strong>13 Mar:</strong> Week closes at Rs.726.75, down 2.24%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.743.40</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-val..."
      },
      {
        "title": "Windlas Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/windlas-biotech-ltd-is-rated-sell-3882611",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_mojoScore_3882611.png",
        "date": "2026-03-10 10:10:18",
        "description": "Windlas Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Windlas Biotech Ltd Stock Falls to 52-Week Low Amidst Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-stock-falls-to-52-week-low-amidst-market-downturn-3880306",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_priceRelatedfactors_3880306.png",
        "date": "2026-03-09 13:56:49",
        "description": "Windlas Biotech Ltd’s shares declined sharply to a new 52-week low of Rs.708.9 on 9 Mar 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns. The stock has underperformed its sector and the broader market over the past year, reflecting subdued financial results and valuation pressures."
      },
      {
        "title": "Windlas Biotech Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-faces-bearish-momentum-amid-technical-downgrade-3879097",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_technicaldot_3879097.png",
        "date": "2026-03-09 08:01:59",
        "description": "Windlas Biotech Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. The stock’s recent price action, combined with mixed signals from MACD, RSI, and moving averages, suggests increasing downside pressure amid a challenging market environment for the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 277,
    "sid": "1003519",
    "stock_news_url": "https://www.marketsmojo.com/news/windlas-biotech-1003519"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "20-Mar-2026",
      "details": "Result of Postal Ballot",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "20-Mar-2026",
      "details": "Result of Postal Ballot",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "13-Mar-2026",
      "details": "Allotment of equity shares pursuant to Windlas Biotech Limited- Employee Stock Option Plan 2021 and WBL Employee Stock Option Scheme 2023",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Windlas Biotech Ltd has declared <strong>116%</strong> dividend, ex-date: 21 Jul 25",
          "dt": "2025-07-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Windlas Biotech’s Mixed Week: +0.01% Price, -0.28% Sensex Tell the Story

2026-03-21 12:01:03

Key Events This Week

16 Mar: Stock hits 52-week low at Rs.699.35 amid continued downtrend

17 Mar: Price rebounds sharply by 2.21% to Rs.724.15

18 Mar: Further gains of 1.12% to Rs.732.25

19 Mar: Sharp decline of 1.99% to Rs.717.65 on heavy market sell-off

20 Mar: Recovery with 1.27% gain to close at Rs.726.80

Windlas Biotech Declines 2.24% Amid Valuation Shift and Bearish Momentum

2026-03-14 10:06:31

Key Events This Week

09 Mar: Stock hits 52-week low at Rs.708.90 amid market downturn

09 Mar: Technical downgrade to Sell rating confirmed bearish momentum

09 Mar: Valuation shifts to attractive rating despite price weakness

13 Mar: Week closes at Rs.726.75, down 2.24%

stock-recommendationAnnouncement

Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

20-Mar-2026 | Source : BSE

Result of Postal Ballot

Shareholder Meeting / Postal Ballot-Scrutinizers Report

20-Mar-2026 | Source : BSE

Result of Postal Ballot

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

13-Mar-2026 | Source : BSE

Allotment of equity shares pursuant to Windlas Biotech Limited- Employee Stock Option Plan 2021 and WBL Employee Stock Option Scheme 2023

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Windlas Biotech Ltd has declared 116% dividend, ex-date: 21 Jul 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available